Sponsored Links

Alliance Optimizes Design Of Cancer Trials To Provide Best Patient Outcomes PDF Print E-mail
Medical News - Clinical Trials and Drug Trials
TGen Drug Development (TD2) and Imaging Endpoints have teamed up to enable the rapid development of anti-cancer drugs and deliver them faster to patients in need, the companies announced today. "The highest quality medical imaging provided by Imaging Endpoints is one more weapon in TD2's arsenal," said Dr...

Read more: Clinical Trials / Drug Trials News From Medical News Today